INVESTMENT STRATEGY – A BALANCED PORTFOLIO
Medical Services Sector, [ VALUE ]
R & D Sector, [ VALUE ]
Approximately 40 % of capital to be deployed in medical technologies, bioscience and research and development intensive companies(“ R & D Sector”) including the following sub-sectors:
• Drug development
• Innova + ve medical devices and equipment
• Healthcare supplements and natural remedies
Approximately 60 % of capital to be deployed in consumer-centric medical services sectors(“ Medical Services Sector”) including the following sub-sectors:
• Pharmaceu + cal produc + on and distribu + on
• Hospital & clinics and pharmacy chains
• Healthcare services that support the healthcare system